Skip to Main Content


Won dismissal of an antitrust suit involving the sale of hundreds of millions of dollars of cancer drugs against a multinational pharmaceutical company and successfully defended the ruling on appeal.

Date: 09.09.22


Andrew S. Gehring
Of Counsel – Colorado practice temporarily authorized pending admission under C.R.C.P. 205.6
P. 303.244.1940
F. 303.244.1879
View Bio

Stay Up To Date

Subscribe to receive news and insights from WTO.

Sign Up